Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
| 56.77 Delayed Data As of 3:59pm ET |  +2.05 / +3.75%Today’s Change | 19.51 Today|||52-Week Range 73.72 | -10.50% Year-to-Date |
Latest ARWR News | Press Releases
| Why Arrowhead Pharmaceuticals Stock Jumped Today Oct 15 / MotleyFool.com - Paid Partner Content | If You Invested $1,000 in Johnson & Johnson in January, This Is How Much You Would Have Today Oct 15 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 54.72 |
| Today’s open | 54.78 |
| Day’s range | 54.78 - 58.46 |
| Volume | 67,954 |
| Average volume (3 months) | 1,398,797 |
| Market cap | $5.0B |
Data as of 3:59pm ET, 10/21/2020
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -169.42% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +945.67% |
| P/E ratio | NM |
| Price/Sales | 16.46 |
| Price/Book | 19.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IOVAIovance Biotherapeut... | -0.89 | -2.35% |
| BPMCBlueprint Medicines ... | -2.23 | -2.17% |
| NVAXNovavax Inc | -7.36 | -7.48% |
| EBSEmergent BioSolution... | -3.49 | -3.61% |
Data as of 4:47pm ET, 10/21/2020
Financials
| Next reporting date | December 15, 2020 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $168.8M |
| Annual profit (last year) | $68.0M |
| Net profit margin | 40.27% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pasadena, California |
Forecasts
